BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 12721924)

  • 1. Development of the Global Measles Laboratory Network.
    Featherstone D; Brown D; Sanders R
    J Infect Dis; 2003 May; 187 Suppl 1():S264-9. PubMed ID: 12721924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the World Health Organization global measles and rubella quality assurance program, 2001-2008.
    Stambos V; Leydon J; Riddell M; Clothier H; Catton M; Featherstone D; Kelly H
    J Infect Dis; 2011 Jul; 204 Suppl 1():S499-505. PubMed ID: 21666206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of the global measles and rubella laboratory network 2005-09.
    Featherstone DA; Rota PA; Icenogle J; Mulders MN; Jee Y; Ahmed H; de Filippis AM; Ramamurty N; Gavrilin E; Byabamazima C; Dosseh A; Xu W; Komase K; Tashiro M; Brown D; Bellini WJ; Strebel P
    J Infect Dis; 2011 Jul; 204 Suppl 1():S491-8. PubMed ID: 21666205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations from an ad hoc Meeting of the WHO Measles and Rubella Laboratory Network (LabNet) on use of alternative diagnostic samples for measles and rubella surveillance.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Jun; 57(24):657-60. PubMed ID: 18566565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Measles Laboratory Network in the region of the Americas.
    Venczel L; Rota J; Dietz V; Morris-Glasgow V; Siqueira M; Quirogz E; Rey G; de Quadros C
    J Infect Dis; 2003 May; 187 Suppl 1():S140-5. PubMed ID: 12721905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Measles and Rubella Laboratory Network, January 2004-June 2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Nov; 54(43):1100-4. PubMed ID: 16267497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.
    Bertagnolio S; Derdelinckx I; Parker M; Fitzgibbon J; Fleury H; Peeters M; Schuurman R; Pillay D; Morris L; Tanuri A; Gershy-Damet GM; Nkengasong J; Gilks CF; Sutherland D; Sandstrom P
    Antivir Ther; 2008; 13 Suppl 2():49-57. PubMed ID: 18575191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced laboratory surveillance for the elimination of rubella and congenital rubella syndrome in the Americas.
    Bispo de Filippis AM; Icenogle J; Matus CR; Andrus JK
    J Infect Dis; 2011 Sep; 204 Suppl 2():S652-8. PubMed ID: 21954262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of standards and training in preparing for accreditation.
    Woodcock S; Fine G; McClure K; Unger B; Rizzo-Price P
    Am J Clin Pathol; 2010 Sep; 134(3):388-92. PubMed ID: 20716794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving global virologic surveillance for measles and rubella.
    Rota PA; Brown KE; Hübschen JM; Muller CP; Icenogle J; Chen MH; Bankamp B; Kessler JR; Brown DW; Bellini WJ; Featherstone D
    J Infect Dis; 2011 Jul; 204 Suppl 1():S506-13. PubMed ID: 21666207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute flaccid paralysis surveillance systems for expansion to other diseases, 2003-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Dec; 53(47):1113-6. PubMed ID: 15573029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating measles and rubella surveillance: the experience in the Caribbean.
    Irons B; Carrasco P; Morris-Glasgow V; Castillo-Solórzano C; de Quadros CA
    J Infect Dis; 2003 May; 187 Suppl 1():S153-7. PubMed ID: 12721907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global measles elimination efforts: the significance of measles elimination in the United States.
    Strebel PM; Henao-Restrepo AM; Hoekstra E; Olive JM; Papania MJ; Cochi SL
    J Infect Dis; 2004 May; 189 Suppl 1():S251-7. PubMed ID: 15106119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learned from establishing and evaluating indicators of the quality of measles surveillance in the United States, 1996-1998.
    Harpaz R; Papania MJ; Fujii KE; Redd SB; Wharton ME; Redd SC; Gindler J
    J Infect Dis; 2004 May; 189 Suppl 1():S196-203. PubMed ID: 15106111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles surveillance: guidelines for laboratory support.
    Can Commun Dis Rep; 1999 Dec; 25(24):201-16. PubMed ID: 10715907
    [No Abstract]   [Full Text] [Related]  

  • 16. The World Health Organization African region laboratory accreditation process: improving the quality of laboratory systems in the African region.
    Gershy-Damet GM; Rotz P; Cross D; Belabbes el H; Cham F; Ndihokubwayo JB; Fine G; Zeh C; Njukeng PA; Mboup S; Sesse DE; Messele T; Birx DL; Nkengasong JN
    Am J Clin Pathol; 2010 Sep; 134(3):393-400. PubMed ID: 20716795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The laboratory confirmation of suspected measles cases in settings of low measles transmission: conclusions from the experience in the Americas.
    Dietz V; Rota J; Izurieta H; Carrasco P; Bellini W
    Bull World Health Organ; 2004 Nov; 82(11):852-7. PubMed ID: 15640921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for active surveillance of selected communicable diseases.
    O'Leary MJ
    Pac Health Dialog; 2000 Sep; 7(2):118-21. PubMed ID: 11588913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current status of forensic science laboratory accreditation in Europe.
    Malkoc E; Neuteboom W
    Forensic Sci Int; 2007 Apr; 167(2-3):121-6. PubMed ID: 16876355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Measles elimination programme on the world and Poland].
    Makówka A; Gut W; Litwińska B
    Przegl Epidemiol; 2007; 61(1):135-42. PubMed ID: 17702452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.